Evidence Synthesis Series – Webinar 2

Since 2021, more than 20 states have passed legislation requiring the coverage of biomarker testing by state-regulated insurers – typically including both commercial plans and state Medicaid agencies. This presentation explores the impetus for this recent trend and uses a 50-state review to explain the structure of these laws and their potential impact on Medicaid programs and their coverage policies. Recorded live on Thursday, May 22, 2025. 

You may download the PowerPoint if you’d like to follow along with the webinar!